The hits keep coming for embattled MMA promotion Strikeforce after the Nevada State Athletic Commission revealed former light heavyweight champ Muhammed Lawal had tested positive for Drostanolone, an anabolic steroid. Lawal’s result stemmed from his bout against previously unbeaten Lorenz Larkin earlier this month at Strikeforce: Rockhold vs. Jardine.
According to NSAC executive Keith Kizer, while a specific sentence has not been imposed yet, it’s likely Lawal will face a 9-12 month suspension and be fined 30-50% of his purse (possibly more). It’s also probable his win over Larkin will be overturned and labeled as a “No Contest”.
Lawal is the second athlete on the roster to test positive for recent PED use with Cristiane Santos being the other. Santos was suspended for a year, fined $2500, and stripped of her featherweight title.
Particularly tricky for Lawal is the fact he will be a free agent in February as the bout against Larkin was the last on his Strikeforce contract. The fight was his second appearance in the ring since suffering a serious knee injury in 2010 that kept him out of action for a year.
No official comment on the situation has surfaced from Lawal, Strikeforce CEO Scott Coker, or UFC President Dana White as of this report.
PHOTO CREDIT – STRIKEFORCE